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ABSTRACT. Foot and mouth disease (FMD) is a highly contagious viral disease causes a serious economic impact 
on livestock production and trading. FMD is an endemic disease in Egypt and a national control program that depends 
on routine obligatory vaccination of all ruminant species is being followed for disease control. A nation-wide epidemic 
of FMD was commenced in early 2015 and typical clinical signs of the disease were observed even in vaccinated an-
imals. The morbidity and case fatality rates were high enough to be investigated. In the current study, non-vaccinated 
and vaccinated animals of different sex and ages were examined to evaluate the efficacy of FMD different vaccines 
used in Egypt. Clinical, post-mortem and serological examinations were used to confirm the infection, while the 
molecular investigation was applied to identify the serotype responsible for this epidemic. The incidence rate and the 
attributable proportion (fraction) of FMD cases which could be avoided by vaccination and vaccine efficacy were 
calculated. The obtained results confirmed the infection with FMD virus (FMDV) serotype O in both non-vaccinated 
and vaccinated animals. The incidence of FMD was 86.67% among non-vaccinated animals, while it was ranged from 
15% to 31.8% among vaccinated animals according to the type of vaccine used. The attributable fraction was 73.9% 
and the efficacy of the three used vaccines was 63.3%, 76.92% and 82.25% for Tri-Aphthovac, VSVRI and Meriel 
vaccines, respectively. In conclusion, vaccination in Egypt is able to minimize the magnitude of outbreaks caused by 
the same serotype found in the vaccine but was not able to prevent the infection and eliminate the disease. The highest 
vaccination efficacy was found in Mid-aged animals and male cattle. 
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INTRODUCTION
Foot and mouth disease (FMD) is a highly conta-gious disease of cloven-hoofed animals. Foot and 
Mouth Disease virus (FMDV) virus belongs to genus 
Aphthovirus of family Picornaviridae and has 7 dis-
tinct serotypes under which many subtypes exist. In 
Egypt, outbreaks are being reported since 1950 and 
FMDV serotype O is the most prevalent circulating 
serotype in most of these outbreaks (Aidaros, 2002; 
Knowles, et al., 2007). FMDV serotype A was report-
ed in 1953, 1956, 1958, 1967 and in a major outbreak 
during 2006 (Mackay et al., 1998; Farag et al., 2006; 
Knowles et al., 2007). In addition, FMDV serotype 
SAT2 was reported in 1950 and a major outbreak in 
2012 (FAO, 2012; Kandeil et al., 2013; Shawky et al., 
2013).
The disease has serious economic effects on bo-
vine production and trading because of its trans- 
boundary nature of transmission (OIE, 2009). FMD 
is characterized by fever, lameness, oral lesions and 
marked salivation. Carrier state usually develops 
when immunized animals are subjected to infection 
as well as after the clinical recovery of the diseased 
animals. Control of FMD depends on the prevention 
of virus transmission from infected to susceptible an-
imals (in free countries) or by reducing the number of 
susceptible animals through vaccination (in endemic 
countries) (Aidaros, 2002). FMD vaccines are usual-
ly multivalent because of the limited cross protection 
between FMDV serotypes (Kandeil et al., 2013). In 
Egypt, three different FMD vaccines are available; the 
governmental vaccine prepared by Veterinary Serum 
and Vaccine Research Institute (VSVRI, Abbasia, 
Egypt), Tri apthovac vaccine produced by ME VAC 
company (Cairo-Egypt) and polyvalent Merial vac-
cine (Merial, France). The two former vaccines con-
tain inactivated A, O and SAT2 serotypes of FMDV. 
The last vaccine is a commercial vaccine being pur-
chased privately on a wide scale of the farmers, es-
pecially large farms to control FMD. This vaccine 
contains 6 serotypes of FMDV and this is the reason 
of preference to it by some farmers who believe that 
this vaccine is more protective and could prevent the 
deleterious effect of FMD. The first two vaccines are 
being used in the national control program carried out 
by the general organization of Veterinary Services 
(GOVS). This program relies on the vaccination of all 
ruminant species except camels in Egypt with FMD 
vaccine twice a year. The vaccination coverage every 
year does not reach the required figure of target an-
imal population targeted by vaccination due to lack 
of funding to produce sufficient doses of vaccine ev-
ery year. This study aimed to assess the vaccination 
efficacy of the three mentioned vaccines under the 
field conditions at Kafrelsheikh Governorate (Egypt), 
describe the main clinical signs in clinically infected 
animals and identify the circulating FMDV serotype 
in both non-vaccinated and vaccinated animals in this 
locality. 
MATERIAL AND METHODS 
Ethical statement This study was conducted fol-
lowing the ethical protocols and guidelines of the 
Medical Ethics Committee, Faculty of Medicine, As-
siut University, Egypt.
Study area 
The current study was conducted in Kafrelsheikh 
Governorate; an area of 3,437 km² with a very high 
density of livestock in heart of the Nile Delta. The 
Governorate consists of 10 districts and 206 villages. 
Kafrelsheikh is located in the northern part of Egypt, 
along with the western branch of the Nile and its cap-
ital is Kafrelsheikh City (Fig. 1).
Figure 1. Map shows the area of the study. 
Animals
 A total of 180 cattle were selected randomly un-
der the field conditions during 2015 FMD outbreak 
in Kafrelsheikh Governorate. Animals included in 
the study were divided into two groups, 105 animals 
were non-vaccinated and 75 animals were vaccinated 
according to the vaccination program in Egypt (two 
doses with 6 month interval). These vaccinated ani-
mals were vaccinated with one of the three different 
vaccines commonly used in Egypt; 40 and 22 animals 
were vaccinated with the vaccine produced by Veter-
inary Serum and Vaccine Research Institute (VSVRI) 
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and Tri-Aphthovac vaccine (commercial vaccine pro-
duced by the Middle East for Vaccines ( ME VAC ) 
company), respectively. These vaccines are being used 
in the national compulsory vaccination campaigns of 
the GOVS. Also, 13 animals were vaccinated with the 
commercial vaccine produced by Meriel. 
Clinical examination
The animals were routinely examined for the clin-
ical symptoms of FMD with special attention for the 
body temperature, mouth cavity, inter-digital space 
and heart sounds (Jackson and Cockcroft, 2002)
Serological Diagnosis
During the virus replication in the infected animals 
there are different types of the non-structural proteins 
(NSPs) are generated and they are a potential target 
for the immune system. Therefore, those infected an-
imals produce a considerable titer of antibodies (Abs) 
against NSPs. These Abs are the target of 3ABC ELI-
SA test to differentiate between clinically infected or 
carrier animals from immunized animals after vaccine 
application (Brocchi et al., 2006; Clavijo et al., 2004). 
Serum samples were collected from animals includ-
ed in the study and tested by SVANOVIR® FMDV 
3ABC-Ab ruminant (Boehringer Ingelheim Svanova, 
Sweden). This ELISA kit differentiates between the 
antibodies of the active infection and vaccination and 
positive samples have percent positive positivity (PP) 
≥48 
Histopathology 
Tissue samples from the oral and lingual mucosa 
were collected from clinically infected animals. Oral, 
lingual mucosa heart and lung were collected from 
the dead animals; all these samples were subjected to 
histopathology (Alexandersen, 2003; Alexandersen 
and Mowat, 2005).
Molecular Diagnosis
RNA-Extraction 
Tissue samples and vesicular fluid were collected 
from clinically infected animals. Samples transport-
ed to the laboratory on ice in viral transport media 
containing equal volumes of glycerol and phosphate 
buffered saline (pH 7.2- 7.6). Viral RNA was extract-
ed using the GeneJET RNA Purification Kit (Thermo 
Fisher SCIENTIFIC - K0731). 
Reverse Transcription PCR (RT-PCR) 
 All samples underwent testing using a two-step 
RT-PCR. During the first step, Applied Biosystem Kit 
Cat. No. 4374966 was used for cDNA synthesis. All 
cDNAs were tested using the P1/P2 universal prim-
ers, as well as the serotype-specific primers, respec-
tively (Table 1). Thermal cycling conditions for the 
universal primers were as follows: 95 ℃ for 5 min, 
followed by 45 cycles of 94 ℃ for 30 seconds, 48°C 
for 30 seconds, and 72 ℃ for 1 min. A final extension 
was performed at 72 ℃ for 10 minutes. The annealing 
temperature (48 ℃) was modified when serotype-spe-
cific primers were used. It was 46 ℃ for serotype O 
primers, 60 ℃ and 56 ℃ for general SAT and sero-
type SAT2 primers and 55 ℃ for serotype A primers 
(EL-Kholy et al., 2007; EL-Shehawy et al., 2011; EL-
Khabaz and AL-Hosary, 2017).
Gel Electrophoresis 
The PCR products were subjected to 1% agarose 
gel electrophoresis using ethidium bromide staining 
and gel documentation system to detect positive bands 
216, 402, >700, 880, 863-866 bp which are specific of 
FMD universal primer, serotype O, SAT, SAT2 and 
Serotype A, respectively. 
Table 1. Different primer used during this study according to EL-Kholy et al., 2007 and EL-Shehawy et al., 2011.
Primer Sequence (5’ to 3’) Length (nt) Specific band
Universal primer
P1
P2
5’- CCTACCTCCTTCAACTACGG-3’
5’-GAAGGGCCCAGGGTTGGACTC -3’
20
21 216 bp
Serotype O
1D/2B region
PH1
PH2
5’-AGC TTG TAC CAG GGT TTG GC-3’
5’-GCT GCC TAC CTC CTT CAA-3’
20
18
402 bp
Serotype SAT 
primers
SAT-ID209F
FMD-2B208R
5’CCACATACTACTTTTGTGACCTGGA -3’
5’-ACAGCGGCCATGCACGACAG -3’
25
20
≥700 bp
Serotype A 
primers
PH9
PH10
5’-TAC CAA ATT ACA CAC GGG AA-3’
5’-GAC ATG TCC TCC TGC ATC TG -3’
22
20
863-866 bp
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Epidemiological examination
Risk “Cumulative Incidence” was calculated in 
both non-vaccinated and vaccinated groups according 
to the following equation 
Number of disease onsets/ the number of animals 
exposed to risk x 100
The attributable fraction which means the expect-
ed percentage of reduction in number cases following 
vaccination and was calculated according to the fol-
lowing equation:
(Number of disease onsets/ the number of animals 
exposed to risk) x 100
The attributable fraction which means the expect-
ed percentage of reduction in number cases following 
vaccination and was calculated according to the fol-
lowing equation:
((The Risk for exposed group - risk for the unex-
posed group)/ Risk for exposed group) x100
Vaccine efficacy or Vaccine effectiveness for each 
vaccine separately was calculated according to the 
following equation
((Risk among non-vaccinated group − risk among 
the vaccinated group)/ Risk among the non-vaccinat-
ed group)) X 100 (Thrusfield, 2005).
Risk estimates and vaccine efficacy were also esti-
mated for different age groups and sex of the animals 
used in this study.
RESULTS
Results of clinical, post-mortem and 
histopathological exanimation
The entire seropositive animal showed the clini-
cal symptoms of the disease which include fever (≥40 
Cº), excessive salivation, vesicles and erosions on 
the dorsum of the tongue and hard palate and inter-
digital space associated with interdigital dermatitis 
and lameness. Some cases suffered from additional 
complications like inapetance, detached claws, ero-
sions and ulceration on teats and udder and incurable 
chronic mastitis. Some cases died suddenly without 
developing any clinical signs.
Fifty-three animals died due to infection with 
FMD (12 animals from the vaccinated group and 41 
from the non-vaccinated group). All of them showed 
the clinical signs of the disease. All of these animals 
were subjected to post-mortem examinations showed 
congestion of the heart and lung. Histopathological 
examination revealed the presence of the hydropic 
degeneration in spinosum cells at covering oral mu-
cosa, this degeneration leads to the appearance of ve-
sicular lesions and subsequently followed by erosive 
stomatitis. Also, histopathological examination re-
vealed the occurrence of congestion and hemorrhage 
of the myocardium, lymphocytic interstitial myocar-
ditis, myocardiolysis and extensive myocardiolysis 
with lymphocytic cell infiltration which is one of the 
pathognomonic lesions of FMD affections (Fig. 2, 3).
Figure 2. Histopathological finding (I) of heart (A, B, C&D) 
and oral mucosa (E, F, G &H) from calves infected with FMD. 
A, Sever congestion (star) and hemorrhage (arrow) in the myo-
cardium (bar=50). B, Lymphocytic interstitial myocarditis (ar-
row) (bar=50) C, Myocardiolysis (star) (bar=100). D, Extensive 
myocardiolysis (star) with lymphocytic cell infiltration (arrow) 
(bar=50). E&F, Hydropic degeneration in spinosum cells at the 
covering oral mucosa (arrow) (bar=100 &bar=50 respectively). 
G, Vesicular stomatitis (star) (bar=50). H, Erosive stomatitis 
(notched arrow) (bar=100). 
Figure 3. (A) Sever congestion of myocardium and (B) Sever 
congestion of the lung.
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Table 2. Incidence rates in both unvaccinated and vaccinated animals and vaccines efficacy rates.
Non-
Vaccinated Seropositive Seronegative Incidence
Vaccinated Seropositive Seronegative Incidence Efficacy
Tri-
Aphthovac-
vaccine
(22) 7 15 31.8 % 63.3%
(105) 91 14 86.67
(VSVRI) 
Vaccine (40)
Seropositive Seronegative Incidence Efficacy
8 32 20 % 76.92 %
Meriel 
vaccine
(13)
Seropositive Seronegative Incidence Efficacy
2 11 15.38 % 82.25 %
Table 3. Incidence rates in both unvaccinated and vaccinated animals and vaccines efficacy rates according to animal’s sex and age.
Unvaccinated Vaccinated
sex seropositive seronegative incidence seropositive seronegative incidence Vaccine efficacy
Females 52 8 86.7% 12 28 30% 70%
Male 39 6 86.7% 5 30 14.28% 85.71%
Unvaccinated Vaccinated
Age seropositive seronegative incidence seropositive seronegative incidence Vaccine efficacy
Blow one year 9 0 100% 12 8 60% 40%
↑1 year:↓5 years 62 14 81.58% 4 50 7.4% 92.6%
↑5 year 20 0 100% 1 0 100% 0%
Results of the serological and epidemiological 
examination
Within the non-vaccinated group 91 out of 105 
animals were seropositive (86.7%), while within the 
vaccinated group only 17 out of 75 animals were se-
ropositive (22.7%); (7, 8 and 2 seropositive out of 22, 
40 and 13 selected animals vaccinated with Tri-Aph-
thovac, VSVRI and Meriel vaccines, respectively) . 
All these animals were seropositive against the 3ABC 
NSPs of the virus (Table 2).
The vaccine efficacy was 63.3%, 76.9% and 82.3% 
for Tri-Aphthovac, VSVRI and Meriel vaccines, re-
spectively. Attributable fraction for vaccine effective-
ness during this epidemic was 73.9%.
The incidence rate and vaccine efficacy were af-
fected by some risk factors like sex and age. In the 
non-vaccinated group the incidence rate was 86.7% 
in both sexes and 100% in the young animals below 
one year and old animals above five years while it was 
81.58% in animals in mid-age (above one year and 
below five years). In the vaccinated group, the inci-
dence was higher in females than in males. The vac-
cine was more efficient in males than females; 85.71% 
and 70%, respectively. The incidence rate was higher 
in young animals and old animals of the vaccinated 
group and it possibly reflects the low efficacy of the 
vaccine in these age groups (Table 3). 
Results of molecular exanimation
All clinically affected cases were confirmed pos-
itive by using both Universal primer (P1/P2) and 
specific primer for Serotype O 1D/2B region without 
co-infection with other serotypes (Fig. 4).
Figure 4. Left, (M) DNA Marker 100bp, Lanes (1:4) positive 
bands of the universal primer (P1/P2) at 216 bp Right, (M) DNA 
Marker 100bp Lanes (1:4) positive bands of the specific primer 
for Serotype O 1D/2B region at 402 bp.
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DISCUSSION 
Food and mouth disease is an endemic viral dis-
ease in Egypt and it remains one of the main obstacles 
for livestock production. The immunity status of ani-
mals is a key factor which influences the clinical out-
come of FMD and so, poorly immunized animals are 
most probably susceptible to this life-threatening dis-
ease. On the other hand, animals of intermediate im-
munity will develop mild symptoms, while those with 
protective immunity will be asymptomatic. Co-infec-
tion with more than one serotype is another important 
factor influences the clinical severity, the co-infection 
between serotype O and SAT2 was recorded in previ-
ous studies in Assiut Governorate, Upper Egypt (El-
Khabaz and Al-Hosary, 2017). 
Vaccination is the main preventive measure to 
protect animals against FMD (Renjun, et al., 2016) 
particularly in an endemic country of multiple circu-
lating serotypes such as Egypt. On the other hand, all 
of FMD vaccines provide short-lived immunity and 
hence it is important to consider the accurate boost-
er vaccinations to prevent the appearance of clinical 
cases. However, immunization doesn’t prevent the 
development of carrier state and most of the vacci-
nated animals may have antibody response against 
the Non-Structural proteins of this virus, particular-
ly against 3ABC, following their exposure to FMDV 
(Mackay et al., 1998; Parida, 2009). This is maybe 
possibly the reason for the occurrence of seropositive 
animals among vaccinated animals observed in the 
current study. 
The obtained results confirmed that the inactivated 
FMD vaccines provide a protective immunity rang-
ing from 63.3% up to 82.25% according to the type 
of vaccine against infection with FMDV serotype 
O which is the only serotype isolated in this study 
and incriminated in this epidemic. The insufficient 
vaccine efficacy in this study could result from the 
short incubation period of the disease which gives 
the chance for the infection to spread widely before 
the vaccine protective titer achieved. This theory may 
explain the appearance of the clinical case and sud-
den deaths in some vaccinated animals observed in 
the current study. Because of this scenario, farmers 
in Egypt think that the vaccine itself is responsible 
for the development of the clinical cases, particularly 
in official national vaccination campaign where ani-
mals of a village are collected together in one place 
for vaccination. 
The lowest efficacy was observed in case of vac-
cine prepared by ME VAC company - Middle East, 
Egypt (Tri apthovac) followed by the vaccine pre-
pared by VSVRI, abbasia, Cairo, Egypt and the high-
est efficiency was recorded by Merial commercial 
vaccine (Merial, France). This finding may be attribut-
ed to the way of vaccine handling and injection and 
the persons who carry out the process of vaccination. 
Vaccination with the former two vaccines are usually 
applied by paramedical who usually carries out the 
vaccination process during the obligatory field vacci-
nation campaign and this causes many problems with 
the vaccination process. Faults that may have direct 
effects on the vaccine efficacy include the dose, route 
or preservation as well as lack of experience, train-
ing and understanding of the vaccination protocols 
before and after vaccine administration. On the oth-
er hand, commercial vaccine such as Meriel vaccine 
provides much protection because it is usually applied 
by a veterinarian rather than paramedical. This agrees 
with the conclusion of (Fawzy et al., 2017) who de-
clared that vaccination by paramedical and assistant is 
a weak point in the vaccination process due to faults 
being followed during the vaccination process.
 Some other risk factors have direct effects on 
the success of vaccination; these factors include an-
imal’s age and animal’s sex. In the current study, the 
finding of the animal sex comes in agreement with 
previous studies that reported that animal sex has no 
effect on the susceptibility and seropositivity of FMD 
in non-vaccinated animal (Kibore et al., 2013). On 
the other hand, some other studies reported a higher 
incidence rate in female than in males (Hailu et al., 
2010). Animal’s age plays an important role in the 
animal susceptibility as in this study the incidence 
rates were higher in young animals below one year 
and old animals above five years. This finding may 
be closely associated with immunity and the ability to 
produce specific antibodies against this virus (Kibore 
et al., 2013). On the other hand, the vaccine effica-
cy was greatly affected by both animal’s sex and age. 
The vaccine was more efficient in males more than 
females. The incidence rate and efficacy were 14.28% 
and 85.71% in males and 30% and 70% in females, 
respectively. This finding may be attributed to some 
stress factors associated with females like pregnancy 
and lactation which have direct effects on the ability 
of immune system to produce the efficient amount of 
antibodies to protect female animals against this in-
fection. According to the age, the vaccine was more 
efficient during mid-age (above one year and below 
five years) where the incidence rate was 7.41% and 
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the efficiency of vaccination recorded 92.59%. This 
finding also closely related to the ability of the im-
mune system to produce specific antibodies against 
this virus. In old and young animals, the immune sys-
tem is unable to produce enough antibodies (Renjun 
et al., 2016). 
Vaccination against FMD does not provide com-
plete protection against the periodical occurrence of 
outbreaks in Egypt and the whole vaccination process 
in the country needs periodical evaluation and updat-
ing. On the other hand, active surveillance and molec-
ular epidemiological studies are much required to de-
tect any changes in the virus components and disease 
epidemiological patterns.
CONCLUSION
This study showed that the vaccination against 
FMD in Egypt has a protective effect against disease 
spread and it has a big tendency to minimize the se-
verity of outbreaks caused by the same serotype found 
in the vaccine. On the other hand, these vaccines were 
not able to prevent the infection and eliminate the dis-
ease. Vaccination is more possible to protect mid-aged 
animals and males than other age groups and sex. Fi-
nally, we concluded that the vaccine being used has to 
contain the circulating FMDV serotypes in the study 
area and this could be achieved through continues ep-
idemiological surveys and molecular identification of 
circulating virus 
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